-
David Hyman: The spread of the new coronavirus is closer to a "natural event"
Time of Update: 2021-07-28
In view of the current mutation of the new crown virus in many countries and regions in the world, cooperation between countries and the leadership of authoritative international organizations are particularly important .
-
Guocai’s "Contract Renewal Season": Is there a sharp increase in drug prices?
Time of Update: 2021-07-28
The company selected for the centralized procurement of cephalexin capsules in the second batch of national organizations is Huabei Pharmaceutical Hebei Huamin Pharmaceutical, the specification is 0.
-
International scholars: The leak theory of the new crown virus laboratory is a demonizing science
Time of Update: 2021-07-28
International scholars: the "laboratory leak theory" of the new crown virus is a demonized science. Don't let truth become a political victim International scholars: The "laborator
-
Hengrui PD-1 new indication for nasopharyngeal carcinoma will be approved soon
Time of Update: 2021-07-28
April 20, NMPA official website shows, Ka Ruili natalizumab single pharmaceutical in progress and previously treated with second-line chemotherapy after more than a disease or intolerable advanced nasopharyngeal carcinoma patients with indications for listing application (admissibility: CXSS2000045) The approval status is changed to "Pending Approval ".
-
The new super anti-flu medicine is here!
Time of Update: 2021-07-28
As Roche's another major anti-influenza drug after Tamiflu (oseltamivir), only a single medication can shorten the relief time of flu symptoms by more than one day, bringing patients a more convenient treatment plan .
-
Health Commission: 22 new confirmed cases, 2 local cases are in Yunnan
Time of Update: 2021-07-28
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 20 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 20 The l
-
Patients with mild COVID-19 will have symptoms of "long-term COVID-19"
Time of Update: 2021-07-28
International war "epidemic" operation Science and Technology Daily, Beijing, June 24 (Reporter Zhang Mengran) A research analysis of patients with new coronary pneumonia published by the British "Nature Medicine" on the 24th found for the first time that more than half of young and middle-aged (16-30 years old) patients with mild illness who were isolated at home Six months after the initial infection, symptoms of long-lasting dyspnea, loss of taste and smell, fatigue or inattention, and memory loss appeared .
-
Zhong Nanshan talks about COVID-19 prevention and control in Shanghai: Don't worry about getting domestic vaccines
Time of Update: 2021-07-28
Zhong Nanshan said, "If we don't do that, if we don't carry out prevention, control and precise tracking in Guangzhou in the past 20 days, the result of the (mathematics of epidemic scale) model is that more than 7.
-
Sharp observation: Why is the powder direct compression process only popular in foreign countries?
Time of Update: 2021-07-28
In fact, compared to wet granulation and tableting, direct compression can better ensure product quality, improve production efficiency, and has a simple process and save raw materials .
-
Reproductive health research is expected to bring new solutions to patients with preeclampsia
Time of Update: 2021-07-28
Academy president struggles Academy of Sciences According to reports, in 2017 China Ke Xueyuan stem cells and regeneration of the Academy of Medical Innovation Ferring Pharmaceutical jointly established FIRM, aims to integrate China's leading reproductive biology research strength and characteristics of the platform, is committed to applying the conversion reproductive biology basic research and to promote scientific research , To provide solutions for the prevention, diagnosis, treatment and rehabilitation of related diseases in the field of reproductive health.
-
Experts disclose in detail the treatment of people infected with the delta variant
Time of Update: 2021-07-28
Early intervention with Chinese and Western medicine cooperation-experts disclose in detail the treatment of patients infected with delta variant strains Early intervention with Chi
-
Health Commission: 23 new cases were confirmed on July 2, all imported from abroad
Time of Update: 2021-07-28
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 2 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 2 The lat
-
Hengrui PD-1 nasopharyngeal carcinoma indication is officially approved
Time of Update: 2021-07-28
April 29, NMPA official website shows, Ka Ruili natalizumab new indications approved on the market, use for previously treated with second-line chemotherapy, disease progression and after more or intolerable advanced nasopharyngeal carcinoma patients .
-
CDE: Publicly solicit opinions on the guiding principles of 17 varieties
Time of Update: 2021-07-28
Transfer from: CDE Editor: Dandelion-Green Tea On April 12-13, CDE issued 6 notices to solicit opinions on guiding principles . The time limit for soliciting opinions is 1 month from the date of p
-
my country's new crown vaccine vaccination rate exceeds 1.1 billion doses and the vaccination rate exceeds 40%
Time of Update: 2021-07-28
By June 14, the number of inoculation doses exceeded 900 million, from 800 million to 900 million, and it took 6 days .
By June 19, the number of inoculation doses exceeded 1 billion, and it took 5 days .
-
WHO: Delta mutant strain is the most easily transmitted variant of new coronavirus
Time of Update: 2021-07-28
WHO Director-General Tan Desai said that the Delta mutant strain is the most easily transmitted new crown virus mutant found so far.
Tan Desai emphasized that there will be new mutant strains in the future, and the virus will evolve, but the emergence of new mutant strains can be prevented by curbing the spread of the virus .
-
Nearly 20 original research drugs have encountered patent challenges!
Time of Update: 2021-07-28
Chongqing Yaoyou Pharmaceutical challenged the patent of this pharmaceutical preparation, and the State Intellectual Property Office made a complete invalidation decision on ZL200680007187.
Therefore, after the patent for the original compound expired, domestic generic drugs with approved document numbers flocked to the market .
-
How do Qilu and Yilian Biopharmaceuticals add next-generation ADC drugs?
Time of Update: 2021-07-28
03 Conversion of IgG4 to IgG1 The first-generation ADC drug Mylotarg uses IgG4 as an antibody, but IgG4 molecules cannot cause Fc-mediated ADCC, CDC and ADCP effects.
With this technology, ADC drugs with a DAR of 10-12 can be designed, laying the foundation for the use of lower-toxic payloads .
-
Kangmei was exposed to bankruptcy and reorganization!
Time of Update: 2021-07-28
On the evening of May 11, Shanghai Pharmaceuticals issued an announcement stating that in order to support the company's long-term business development, improve the industrial layout, and further enhance the company's overall strength, the company plans to introduce Yunnan Baiyao as a strategic investor through this non-public issuance of A shares .
-
The eve of the fifth batch of national procurement bids: In addition to "low-price selection", what other ways to survive for generic drugs?
Time of Update: 2021-07-28
Great environmental changes "Bring gold" to the end There is no need for academic promotion of generic drugs, because the original drugs have already or basically completed the education of the market .
